Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ImmunoGen (IMGN) News Today

ImmunoGen logo

IMGN Latest News

Artisan International Small-Mid Instl
Artisan International Small-Mid Advisor
Polaris Global Equity Composite Q1 2024 Commentary
3 Potential Biopharma Buyout Targets
CERE Aug 2024 30.000 call
Barclays Keeps Their Hold Rating on ImmunoGen (IMGN)
ImmunoGen (Nasdaq:IMGN) Headline
Trading was temporarily halted for "IMGN" at 07:02 PM with a stated reason of "News pending."...
ImmunoGen (NASDAQ:IMGN) Sees Strong Trading Volume
ImmunoGen (NASDAQ:IMGN) Hits New 52-Week High at $31.24
How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry
IMGN Quantitative Stock Analysis
Get ImmunoGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMGN and its competitors with MarketBeat's FREE daily newsletter.

IMGN Media Mentions By Week

IMGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMGN
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

IMGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMGN Articles
This Week

0

0

IMGN Articles
Average Week

Get ImmunoGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IMGN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners